Literature DB >> 8727168

Reductions in membrane proteins and lipids in basal ganglia of classic Alzheimer disease patients.

C G Gottfries1, B Jungbjer, I Karlsson, L Svennerholm.   

Abstract

Gangliosides and major membrane components were determined in caudate nucleus, putamen, and hippocampus of 12 cases with Alzheimer disease (AD) type I, also termed presenile or pure AD, and in age-matched controls. The concentration of gangliosides, a marker for axodendritic arborization, was reduced to 71% in caudate nucleus, 82% in putamen, and 66% in hippocampus of that in the controls. Significant diminution of total dry solids, protein, and phospholipids was also found in caudate nucleus and was most pronounced in hippocampus. The early signs of extrapyramidal features have been emphasized in AD type I. We now provide evidence that the neostriatum is affected in AD type I (the putamen, however, to a lesser extent than the caudate nucleus). The biochemical changes in these nuclei can be significantly related to scores of impairment of motor performance.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8727168     DOI: 10.1097/00002093-199601020-00004

Source DB:  PubMed          Journal:  Alzheimer Dis Assoc Disord        ISSN: 0893-0341            Impact factor:   2.703


  5 in total

1.  Disturbed choline plasmalogen and phospholipid fatty acid concentrations in Alzheimer's disease prefrontal cortex.

Authors:  Miki Igarashi; Kaizong Ma; Fei Gao; Hyung-Wook Kim; Stanley I Rapoport; Jagadeesh S Rao
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

2.  Displacement currents associated with the insertion of Alzheimer disease amyloid beta-peptide into planar bilayer membranes.

Authors:  J Vargas; J M Alarcón; E Rojas
Journal:  Biophys J       Date:  2000-08       Impact factor: 4.033

3.  Activation of LA-N-2 cell phospholipase D by amyloid beta protein (25-35).

Authors:  I N Singh; G Sorrentino; J N Kanfer
Journal:  Neurochem Res       Date:  1998-10       Impact factor: 3.996

4.  Modulation of Neurolipid Signaling and Specific Lipid Species in the Triple Transgenic Mouse Model of Alzheimer's Disease.

Authors:  Estibaliz González de San Román; Alberto Llorente-Ovejero; Jonatan Martínez-Gardeazabal; Marta Moreno-Rodríguez; Lydia Giménez-Llort; Iván Manuel; Rafael Rodríguez-Puertas
Journal:  Int J Mol Sci       Date:  2021-11-12       Impact factor: 5.923

5.  Particular CSF sphingolipid patterns identify iNPH and AD patients.

Authors:  Enrica Torretta; Beatrice Arosio; Pietro Barbacini; Martina Casati; Daniele Capitanio; Roberta Mancuso; Daniela Mari; Matteo Cesari; Mario Clerici; Cecilia Gelfi
Journal:  Sci Rep       Date:  2018-09-11       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.